Terumo Co. (OTCMKTS:TRUMY) Sees Significant Decrease in Short Interest

Terumo Co. (OTCMKTS:TRUMY - Get Free Report) was the target of a large decline in short interest in May. As of May 15th, there was short interest totalling 30,200 shares, a decline of 44.5% from the April 30th total of 54,400 shares. Based on an average daily trading volume, of 180,600 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.0% of the company's stock are short sold.

Terumo Stock Down 2.6%

Shares of OTCMKTS TRUMY traded down $0.49 during trading hours on Friday, hitting $18.28. The stock had a trading volume of 182,061 shares, compared to its average volume of 166,788. The company has a market capitalization of $27.06 billion, a P/E ratio of 35.15 and a beta of 0.88. The firm's 50-day moving average price is $18.88 and its two-hundred day moving average price is $18.99. Terumo has a 52 week low of $14.06 and a 52 week high of $21.22. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.70 and a current ratio of 2.94.

Terumo (OTCMKTS:TRUMY - Get Free Report) last announced its quarterly earnings results on Wednesday, May 14th. The company reported $0.08 EPS for the quarter, missing the consensus estimate of $0.15 by ($0.07). The company had revenue of $1.79 billion during the quarter, compared to analyst estimates of $1.79 billion.

Terumo Company Profile

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.